Insmed (INSM) Other Accumulated Expenses (2011 - 2026)
Insmed (INSM) posted Other Accumulated Expenses of $37.77 million for Q2 2026, up 362.8% from $8.16 million a year earlier and up 62.2% from the prior quarter.
Insmed (INSM) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Insmed's Other Accumulated Expenses came in at $17.1 million, up 170.4% from FY2024.
- Annual Other Accumulated Expenses has increased for three consecutive years, with a four-year compound annual growth rate of 26.6% (FY2021 to FY2025).
- In prior years, Insmed's Other Accumulated Expenses was $6.32 million in FY2024 (+11.5%), $5.67 million in FY2023 (+20.5%), $4.71 million in FY2022 (-29.2%) and $6.66 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses in data going back to Q4 2011.
- On a year-over-year basis, Other Accumulated Expenses has increased in each of the last four quarters, with growth averaging 89.0% over the last eight quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2026, with growth of 362.8%; the weakest was Q4 2022, with a decline of 29.2%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $23.29 million (Q1 2026), $17.1 million (Q4 2025) and $9.37 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Insmed | 24.26 Bn | 18.76 Bn | 358.27 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.77 Mn |
| Mar 31, 2026 | 23.29 Mn |
| Dec 31, 2025 | 17.10 Mn |
| Sep 30, 2025 | 9.37 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | 10.94 Mn |
| Dec 31, 2024 | 6.32 Mn |
| Sep 30, 2024 | 8.53 Mn |
| Jun 30, 2024 | 8.65 Mn |
| Mar 31, 2024 | 10.21 Mn |
| Dec 31, 2023 | 5.67 Mn |
| Sep 30, 2023 | 5.98 Mn |
| Jun 30, 2023 | 6.23 Mn |
| Mar 31, 2023 | 6.17 Mn |
| Dec 31, 2022 | 4.71 Mn |
| Sep 30, 2022 | 5.32 Mn |
| Dec 31, 2021 | 6.66 Mn |
| Mar 31, 2020 | 78,000.00 |
| Dec 31, 2019 | 280,000.00 |
| Sep 30, 2019 | 130,000.00 |
Insmed Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();